W. Young

Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)

C. O’Neill, M. Katz, J. Coates, 2014, Journal of neuroscience research.

AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease

B. Davidson, E. Lysenko, L. Tecedor, 2015, Science Translational Medicine.

Human monoclonal antibody against Forssman antigen.

I. Bernstein, S. Hakomori, M. Cooney, 1980, Science.

AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease

B. Davidson, E. Lysenko, L. Tecedor, 2015, Science Translational Medicine.